WuXi XDC Cayman (FRA:L74) EBIT per Share : €0.02 (TTM As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman EBIT per Share?

WuXi XDC Cayman's EBIT per Share for the three months ended in Jun. 2023 was €0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €0.02.

During the past 12 months, the average EBIT per Share Growth Rate of WuXi XDC Cayman was 89.10% per year. During the past 3 years, the average EBIT per Share Growth Rate was 113.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for WuXi XDC Cayman's EBIT per Share or its related term are showing as below:

FRA:L74' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 113.5 Med: 113.5 Max: 113.5
Current: 113.5

During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of WuXi XDC Cayman was 113.50% per year. The lowest was 113.50% per year. And the median was 113.50% per year.

FRA:L74's 3-Year EBIT Growth Rate is ranked better than
99.42% of 173 companies
in the Medical Diagnostics & Research industry
Industry Median: -2.2 vs FRA:L74: 113.50

WuXi XDC Cayman's EBIT for the three months ended in Jun. 2023 was €14.5 Mil.

WuXi XDC Cayman EBIT per Share Historical Data

The historical data trend for WuXi XDC Cayman's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi XDC Cayman EBIT per Share Chart

WuXi XDC Cayman Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EBIT per Share

0.01

0.02

0.04

WuXi XDC Cayman Quarterly Data
	Dec20	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Dec23
EBIT per Share	Get a 7-Day Free Trial			0.01	-	0.01	0.01	-

WuXi XDC Cayman EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

WuXi XDC Cayman's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	46.279	/	1077.973
=	0.04

WuXi XDC Cayman's EBIT per Share for the quarter that ended in Jun. 2023 is calculated as

	EBIT per Share		(Q: Jun. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	14.529	/	1178.446
=	0.01

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.02

WuXi XDC Cayman (FRA:L74) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

WuXi XDC Cayman EBIT per Share Related Terms

Thank you for viewing the detailed overview of WuXi XDC Cayman's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi XDC Cayman (FRA:L74) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (FRA:L74) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

02268:Hong Kong

Address

No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN

Website

WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.

WuXi XDC Cayman (FRA:L74) Headlines

No Headlines